Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $320,281 - $388,958
-3,495 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $62,787 - $80,360
820 Added 30.65%
3,495 $320,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $609,102 - $890,674
-9,696 Reduced 78.38%
2,675 $211,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $6,594 - $7,341
84 Added 0.68%
12,371 $1.08 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $180,702 - $195,937
-2,208 Reduced 15.23%
12,287 $1.03 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $504,183 - $588,030
-6,918 Reduced 32.31%
14,495 $1.22 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $13 Million - $15.7 Million
-196,023 Reduced 90.15%
21,413 $1.71 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $14.3 Million - $16.1 Million
217,436 New
217,436 $15.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track London & Capital Asset Management LTD Portfolio

Follow London & Capital Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on London & Capital Asset Management LTD with notifications on news.